We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SNT:JSESantam Limited Analysis

Data as of 2026-05-26 - not real-time

ZAC 38,141.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Santam Ltd (SNT.JO) is trading at ZAc 38,141, well below its 30‑day DCF fair value of ZAc 205,262, implying a substantial valuation gap. The stock’s price sits beneath the 20‑day (ZAc 39,045), 50‑day (ZAc 39,804) and 200‑day (ZAc 41,508) simple moving averages, confirming a bearish technical backdrop. Nevertheless, the RSI of 39.4 suggests the shares are approaching oversold territory, hinting at a possible short‑term rebound. The MACD line remains negative with a bearish histogram, reinforcing current downside momentum. At a dividend yield of 4.36 % and a payout ratio of 42.8 %, the dividend appears sustainable, offering attractive income. The market’s “Extreme Greed” sentiment (fear‑greed index 91.6) further fuels upside potential.
Fundamentally, Santam delivers solid growth with 4.9 % revenue expansion, a robust ROE of 33 % and operating margins near 19 %, outpacing many peers. Its price‑to‑earnings multiple of 10.4 is well under the industry average of 16.8, underscoring a value‑oriented entry point. Low beta (0.15) and moderate 30‑day volatility (16.8 %) indicate limited systematic risk, though liquidity is constrained by thin trading volumes. The consensus “Buy” rating, a mean target price of ZAc 47,543 and an upside estimate of roughly 25 % align with a longer‑run appreciation thesis. Given the strong balance sheet, modest debt levels and a resilient dividend, the stock is positioned for sustained performance. Investors should therefore consider accumulating on dips while monitoring support at ZAc 36,100.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below key moving averages indicating bearish trend
  • RSI near oversold levels suggesting potential bounce
  • Thin trading volume increasing short‑term execution risk

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation upside to DCF fair value
  • Strong ROE and low PE relative to industry
  • Sustainable dividend yield supporting total return

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Robust balance sheet with low leverage
  • Consistent earnings growth and high ROE
  • Long‑term dividend sustainability and attractive yield

Key Metrics & Analysis

Financial Health

Revenue Growth4.90%
Profit Margin6.63%
P/E Ratio10.4
ROE33.08%
ROA8.78%
Debt/Equity37.14
P/B Ratio2.8
Op. Cash FlowZAC2.4B
Free Cash FlowZAC13.0B
Industry P/E16.8

Technical Analysis

TrendBearish
RSI39.4
SupportZAC 36,100.00
ResistanceZAC 41,176.00
MA 20ZAC 39,045.55
MA 50ZAC 39,804.60
MA 200ZAC 41,507.52
MACDBearish
VolumeStable
Fear & Greed Index91.64

Valuation

Fair ValueZAC 205,262.34
Target PriceZAC 47,543.83
Upside/Downside24.65%
GradeUndervalued
TypeBlend
Dividend Yield4.36%

Risk Assessment

Beta0.15
Volatility16.80%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.